Review
Open access
Sep 2026
uPAR-directed immunotherapies in solid tumors: current advances and future perspectives
This review provides a comprehensive overview of the principal uPAR-directed immunotherapeutic strategies currently under investigation, including chimeric antigen receptor (CAR) T-cell therapies, multi-epitope vaccines, monoclonal antibodies, and radioligand-based approaches.
Filomena Napolitano, N. Montuori
· Frontiers in Pharmacology · 0 citations